Rena J Eudy-Byrne (Rena Eudy-Byrne)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Rheumatoid Arthritis

Top Venues

British journal of clinical pharmacology

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Rena J Eudy-Byrne, Matthew M Riggs, Amale Hawi, Thomas Sciascia, Shashank Rohatagi
A population pharmacokinetic-pharmacodynamic model evaluating efficacy of nalbuphine extended-release in patients with prurigo nodularis. British journal of clinical pharmacology (2023)
Rena J Eudy-Byrne, Matthew M Riggs, Amale Hawi, Thomas Sciascia, Shashank Rohatagi
A Population Pharmacokinetic-Pharmacodynamic Model Evaluating Efficacy of Nalbuphine Extended-Release in Patients with Prurigo Nodularis. British journal of clinical pharmacology (2023)
Rena J Eudy-Byrne, Nicole Zane, Susan C Adeniyi-Jones, Marc R Gastonguay, Ana Ruiz-Garcia, Gagan Kushal, Walter K Kraft
Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome. Clinical and translational science 14 (6) (2021)
Jia Kang, Rena J Eudy-Byrne, John Mondick, William Knebel, Girish Jayadeva, Karl-Heinz Liesenfeld
Population pharmacokinetics of adalimumab biosimilar adalimumab-adbm and reference product in healthy subjects and patients with rheumatoid arthritis to assess pharmacokinetic similarity. British journal of clinical pharmacology 86 (11) (2020)